LABORATORY RESEARCH Estrogen Controls the Survival of BRCA1-Deficient Cells via a PI3K-NRF2-Regulated Pathway Investigators showed that estrogen (E2) increases the expression of NRF2-dependent antioxidant genes in various E2-responsive cell types. [Proc Natl Acad Sci USA] Abstract Estrogen Receptor Beta as a Novel Target of Androgen Receptor Action in Breast Cancer Cell Lines Researchers demonstrated that mibolerone, a synthetic androgen ligand, up-regulates estrogen receptor (ER)-beta mRNA and protein levels in ER-positive breast cancer cells. [Breast Cancer Res] Abstract | Full Article Eribulin Mesilate Suppresses Experimental Metastasis of Breast Cancer Cells by Reversing Phenotype from Epithelial-Mesenchymal Transition to Mesenchymal-Epithelial Transition States Treatment of triple negative breast cancer cells with eribulin in vitro led to morphological changes consistent with transition from a mesenchymal to an epithelial phenotype. [Br J Cancer] Full Article Conditional Over-Expression of Liver Receptor Homolog-1 in Female Mouse Mammary Epithelium Results in Altered Mammary Morphogenesis via the Induction of Transforming Growth Factor-ß Researchers used siRNA knockdown strategies in order to deplete liver receptor homolog-1 (LRH-1) in breast cancer cells and followed with microarray analysis to identify LRH-1 dependent mechanisms. They identified key genes involved in TGF-ß signaling to be highly responsive to LRH-1 knockdown. [Endocrinology] Abstract Wnt Modulates MCL1 to Control Cell Survival in Triple Negative Breast Cancer Researchers directed their focus on identifying the WNT ligand and its underlying mechanism in triple negative breast cancer cells. [BMC Cancer] Abstract | Full Article Targeting Met and Notch in the Lfng-Deficient, Met-Amplified Triple-Negative Breast Cancer To examine roles of Met and Notch in triple negative breast cancer cells, scientists established two cell lines that harbor Met amplification as well as Lfng deletion, and possess features of basal and claudin-low breast cancer subtypes. [Cancer Biol Ther] Abstract Histone Demethylase RBP2 Is Critical for Breast Cancer Progression and Metastasis By using both human breast cancer cells and genetically engineered mice, researchers demonstrated that RBP2 is critical for breast cancer metastasis to the lung in multiple in vivo, models. [Cell Rep] Full Article | Graphical Abstract CLINICAL RESEARCH Optimum Duration of Neoadjuvant Letrozole to Permit Breast Conserving Surgery The aim of this multicenter, prospective, longitudinal Phase IV study was to establish the optimal duration of neoadjuvant letrozole that would allow breast conservation surgery in patients with early breast cancer who were initially unsuitable. [Breast Cancer Res Treat] Abstract Disseminated Tumor Cells as a Monitoring Tool for Adjuvant Therapy in Patients with Primary Breast Cancer Investigators aimed to assess whether adjuvant systemic therapy has the ability to eradicate disseminated tumor cells (DTC) and to determine the clinical impact of DTC-persistence. [Breast Cancer Res Treat] Abstract |